Clinical Trial Update: Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describing a Phase 2/Phase 3 study of temozolomide combined with intensity-modulated radiation therapy with a simultaneous integrated boos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer with Brain Metastases

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Taizhou Hospital | Conditions: Non Small Cell Lung Cancer Metastatic | Phase 2, Phase 3 | Status: UNKNOWN